Modulation of agonist and antagonist interactions in serotonin 1A receptors by alcohols

FEBS Letters

Volumn 438, Issue 1-2, 1998, Pages 96-100

  Harikumar, K G ^a   Chattopadhyay, Amitabha ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

4 (2' Methoxy) phenyl 1 2' (N 2'' pyridinyl) p fluorobenzamido ethyl piperazine; 4 (2' Methoxy) phenyl 1 2' (N 2'' pyridinyl) p iodobenzamido ethyl piperazine; 8 Hydroxy 2 (di N propylamino)tetralin; Alcohol; Bovine hippocampus; Serotonin 1A receptor

Indexed keywords

2 DIBUTYLAMINO 8 HYDROXYTETRALIN; ALCOHOL DERIVATIVE; MEMBRANE RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ARTICLE; CATTLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ALCOHOLS; AMINOPYRIDINES; ANIMALS; BINDING SITES; BUFFERS; BUTANOLS; CATTLE; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; HEXANOLS; HIPPOCAMPUS; LIGANDS; OCTANOLS; PIPERAZINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SOLUBILITY;

BOVINAE;

EID: 0032582850     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01284-8     Document Type: Article

References (47)

1. Chattopadhyay A., Rukmini R., Mukherjee S. Biophys. J. 71:1996;1952-1960.
2. Jacobs B.L., Azmitia E.C. Physiol. Rev. 72:1992;165-229.
3. Rocha B.A., Scearce-Levie K., Lucas J.J., Hiroi N., Castanon N., Crabbe J.C., Nestler E.J., Hen R. Nature. 393:1998;175-178.
4. Wilkinson, L.O. and Dourish, C.T. (1991) in: Serotonin Receptor Subtypes: Basic and Clinical Aspects (Peroutka, S.J., Ed.), pp. 147-210, Wiley-Liss, New York.
5. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.-C., Hen R. Science. 265:1994;1875-1878.
6. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., Shih J.C., De Maeyer E. Science. 268:1995;1763-1766.
7. Heath M.J.S., Hen R. Curr. Biol. 5:1995;997-999.
8. Artigas F., Romero L., De Montigny C., Blier P. Trends Neurosci. 19:1996;378-383.
9. Bjørkum A.A., Ursin R. Brain Res. Bull. 39:1996;373-379.
10. Crabbe J.C., Phillips T.J., Feller D.J., Hen R., Wenger C.D., Lessov C.N., Schafer G.L. Nature Genet. 14:1996;98-101.
11. Ohno M., Watanabe S. Brain Res. 736:1996;180-188.
12. Yeh S.-R., Fricke R.A., Edwards D.H. Science. 271:1996;366-369.
13. Lopez-Ibor J.J. Br. J. Psychiatry. 153:(Suppl. 3):1988;26-39.
14. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Julius D. Nature. 374:1995;542-546.
15. Pandey G.N. Ann. NY Acad. Sci. 836:1997;182-200.
16. Mann J.J. Nature Med. 4:1998;25-30.
17. Peroutka S.J. J. Neurochem. 60:1993;408-416.
18. Strader C.D., Fong T.M., Graziano M.P., Tota M.R. FASEB J. 9:1995;745-754.
19. Harikumar K.G., Chattopadhyay A. Cell. Mol. Neurobiol. 18:1998;535-553.
20. Chattopadhyay A., Harikumar K.G. FEBS Lett. 391:1996;199-202.
21. Sellers E.M., Higgins G.A., Sobell M.B. Trends Pharmacol. Sci. 13:1992;69-75.
22. Ferreira L., Soares-DaSilva P. Hum. Psychopharmacol. (Suppl.). 6:1991;S21-S24.
23. McBride W.J., Murphy J.M., Yoshimoto K., Lumeng L., Li T.K. Drug Dev. Res. 30:1993;171-177.
24. Pandey S.C., Piano M.R., Schwertz D.W., Davis J.M., Pandey G.N. Alcoholism Clin. Exp. Res. 16:1992;1110-1116.
25. Minami K., Minami M., Harris R.A. J. Pharmacol. Exp. Ther. 281:1997;1136-1143.
26. McCreery M.J., Hunt W.A. Neuropharmacology. 17:1978;451-461.
27. Bruns R.F., Lawson-Wending K., Pugsley T.A. Anal. Biochem. 132:1983;74-81.
28. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Anal. Biochem. 150:1985;76-85.
29. Ho B.Y., Karschin A., Branchek T., Davidson N., Lester H.A. FEBS Lett. 312:1992;259-262.
30. Chanda P.K., Minchin M.C.W., Davis A.R., Greenberg L., Reilly Y., McGregor W.H., Bhat R., Lubeck M.D., Mizutani S., Hung P.P. Mol. Pharmacol. 43:1993;516-520.
31. Sylte I., Edvardsen O., Dahl S.G. Protein Eng. 9:1996;149-160.
32. Kuipers W., Link R., Standaar P.J., Stoit A.R., Van Wijngaarden I., Leurs R., Ijzerman A.P. Mol. Pharmacol. 51:1997;889-896.
33. Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Nature. 305:1983;140-142.
34. Buckholtz N.S., Zhou D., Tabakoff B. Alcohol. 6:1989;277-280.
35. Kung M.-P., Zhuang Z.-P., Frederick D., Kung H.F. Synapse. 18:1994;359-366.
36. Kung H.F., Kung M.-P., Clarke W., Maayani S., Zhuang Z.-P. Life Sci. 55:1994;1459-1462.
37. Thielen R.J., Frazer A. Life Sci. 56:1995;163-168.
38. Kung M.-P., Frederick D., Mu M., Zhuang Z.-P., Kung H.F. J. Pharmacol. Exp. Ther. 272:1995;429-437.
39. Barry J.A., Gawrisch K. Biochemistry. 33:1994;8082-8088.
40. Peoples R.W., Li C., Weight F.F. Annu. Rev. Pharmacol. Toxicol. 36:1996;185-201.
41. Ortells M.O., Lunt G.G. Trends Neurosci. 18:1995;121-127.
42. Ostrowski J., Kjelsberg M.A., Caron M.G., Lefkowitz R.J. Annu. Rev. Pharmacol. Toxicol. 32:1992;167-183.
43. Mitchell D.C., Lawrence J.T.R., Litman B.J. J. Biol. Chem. 271:1996;19033-19036.
44. Klemm W.R. Alcohol. 7:1990;49-59.
45. Ho C., Stubbs C.D. Biochemistry. 36:1997;10630-10637.
46. Klemm W.R., Williams H.J. Alcohol. 13:1996;133-138.
47. Wood W.G., Gorka C., Schroeder F. J. Neurochem. 52:1989;1925-1930.